Skip to main content
Naseema Gangat, MD, Oncology, Rochester, MN

Naseema Gangat MD


Instructor, Internal Medicine, Mayo Medical School

Join to view full profile
  • 200 1st St SWRochester, MN 55905

  • Phone+1 507-284-2511

Dr. Gangat is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
  • Aga Khan Medical College
    Aga Khan Medical CollegeClass of 2002

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2006 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • MPL-Mutated Essential Thrombocythemia: A Morphologic Reappraisal  
    Naseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
  • Determinants of Long-Term Outcome in Type 1 Calreticulin-Mutated Myelofibrosis  
    Naseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature

Press Mentions

  • “How Are the 2026 AML Algorithms Reshaping Frontline Therapy?
    “How Are the 2026 AML Algorithms Reshaping Frontline Therapy?April 1st, 2026
  • Talha Badar: Key Hematologic Malignancy Posters from ASCO26
    Talha Badar: Key Hematologic Malignancy Posters from ASCO26June 2nd, 2026
  • Naveen Pemmaraju: A New Era for Myeloproliferative Neoplasms at SOHO 2026
    Naveen Pemmaraju: A New Era for Myeloproliferative Neoplasms at SOHO 2026September 12th, 2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: